AAAAAA
Results: 1-25/28
PREECLAMPSIA AND FETAL GROWTH-RETARDATION - IS THERE AN ASSOCIATION WITH ANTIPHOSPHOLIPID ANTIBODIES
Authors:
SCHJETLEIN R
HAUGEN G
MOE N
HUSBY H
WISLOFF F
Citation: R. Schjetlein et al., PREECLAMPSIA AND FETAL GROWTH-RETARDATION - IS THERE AN ASSOCIATION WITH ANTIPHOSPHOLIPID ANTIBODIES, Hypertension in pregnancy, 17(1), 1998, pp. 81-92
Authors:
KAASA S
HJERMSTAD MJ
JORDHOY MS
WISLOFF F
LOGE JH
Citation: S. Kaasa et al., COMPLIANCE IN QUALITY-OF-LIFE DATA - A NORWEGIAN EXPERIENCE, Statistics in medicine, 17(5-7), 1998, pp. 623-632
Authors:
HJORTH M
HOMBERG E
RODJER S
TURESSON I
WESTIN J
WISLOFF F
Citation: M. Hjorth et al., SURVIVAL IN CONVENTIONALLY TREATED YOUNGER (LESS-THAN-60 YEARS) MULTIPLE-MYELOMA PATIENTS - NO PROGRESS DURING 2 DECADES, British Journal of Haematology, 102(1), 1998, pp. 354-355
Authors:
NORD E
WISLOFF F
HJORTH M
WESTIN J
Citation: E. Nord et al., COST-UTILITY ANALYSIS OF MELPHALAN PLUS PREDNISONE WITH OR WITHOUT INTERFERON-ALPHA-2B IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - RESULTS FROM ARANDOMIZED CONTROLLED TRIAL, PharmacoEconomics, 12(1), 1997, pp. 89-103
Authors:
BACHGANSMO ET
STRAND O
GODAL HC
WISLOFF F
SKJONSBERG OH
Citation: Et. Bachgansmo et al., DISCREPANCY BETWEEN LATEX AND ELISA D-DIMER VALUES IN SEPSIS MAY BE CAUSED BY HUMAN NEUTROPHIL ELASTASE, Thrombosis and haemostasis, 1997, pp. 2224-2224
Authors:
DJUROVIC S
SCHJETLEIN R
WISLOFF F
HAUGEN G
BERG K
Citation: S. Djurovic et al., INCREASED LEVELS OF INTERCELLULAR-ADHESION MOLECULES AND VASCULAR CELL-ADHESION MOLECULES IN PREECLAMPSIA, British journal of obstetrics and gynaecology, 104(4), 1997, pp. 466-470
Authors:
JACOBSEN EM
WISLOFF F
Citation: Em. Jacobsen et F. Wisloff, A SIMPLE PROCEDURE THAT INCREASES THE SPECIFICITY OF THE ACTIVATED PROTEIN-C RESISTANCE TEST IN SAMPLES CONTAINING ANTIPHOSPHOLIPID ANTIBODIES, Thrombosis research, 86(5), 1997, pp. 385-391
Authors:
BACHGANSMO ET
STRAND O
GODAL HC
WISLOFF F
SKJONSBERG OH
Citation: Et. Bachgansmo et al., DISCREPANCY BETWEEN LATEX AND ELISA D-DIMER VALUES IN SEPSIS MAY BE CAUSED BY HUMAN NEUTROPHIL ELASTASE, Thrombosis research, 86(2), 1997, pp. 141-152
Authors:
SCHJETLEIN R
HAUGEN G
SANDSET PM
WISLOFF F
Citation: R. Schjetlein et al., REDUCED C4B-BINDING PROTEIN IN PREECLAMPSIA, Thrombosis research, 85(2), 1997, pp. 153-158
Authors:
DJUROVIC S
SCHJETLEIN R
WISLOFF F
HAUGEN G
HUSBY H
BERG K
Citation: S. Djurovic et al., ALTERED PLASMA-LEVELS OF LP(A) LIPOPROTEIN AND TGF-BETA-1 IN PREECLAMPSIA, Atherosclerosis, 134(1-2), 1997, pp. 274-274
Authors:
DJUROVIC S
SCHJETLEIN R
WISLOFF F
HAUGEN G
HUSBY H
BERG K
Citation: S. Djurovic et al., PLASMA-CONCENTRATIONS OF LP(A) LIPOPROTEIN AND TGF-BETA(1) ARE ALTERED IN PREECLAMPSIA, Clinical genetics, 52(5), 1997, pp. 371-376
Authors:
WISLOFF F
HJORTH M
Citation: F. Wisloff et M. Hjorth, HEALTH-RELATED QUALITY-OF-LIFE ASSESSED BEFORE AND DURING CHEMOTHERAPY PREDICTS FOR SURVIVAL IN MULTIPLE-MYELOMA, British Journal of Haematology, 97(1), 1997, pp. 29-37
Authors:
JACOBSEN EM
SANDSET PM
WISLOFF F
Citation: Em. Jacobsen et al., DO ANTIPHOSPHOLIPID ANTIBODIES INFLUENCE THE INTRA-VASCULAR LEVELS OFTISSUE FACTOR PATHWAY INHIBITOR (TFPI), Blood, 90(10), 1997, pp. 3234-3234
Authors:
SCHJETLEIN R
HAUGEN G
WISLOFF F
Citation: R. Schjetlein et al., MARKERS OF INTRAVASCULAR COAGULATION AND FIBRINOLYSIS IN PREECLAMPSIA- ASSOCIATION WITH INTRAUTERINE GROWTH-RETARDATION, Acta obstetricia et gynecologica Scandinavica, 76(6), 1997, pp. 541-546
Authors:
SLETNES KE
HOLTE H
HALVORSEN S
JAKOBSEN E
WISLOFF F
KVALOY S
Citation: Ke. Sletnes et al., ACTIVATION OF COAGULATION AND DEEP-VEIN THROMBOSIS AFTER BONE-MARROW HARVESTING AND INSERTION OF A HICKMAN-CATHETER IN ABMT PATIENTS WITH MALIGNANT-LYMPHOMA, Bone marrow transplantation, 17(4), 1996, pp. 577-581
Authors:
JACOBSEN EM
SANDSET PM
WISLOFF F
Citation: Em. Jacobsen et al., LUPUS ANTICOAGULANT AND A FUNCTIONAL, ASSAY FOR TISSUE FACTOR PATHWAYINHIBITOR, Thrombosis research, 83(4), 1996, pp. 339-340
Authors:
JACOBSEN EM
WISLOFF F
Citation: Em. Jacobsen et F. Wisloff, FALSE-NEGATIVE SCREENING-TESTS FOR LUPUS ANTICOAGULANTS - AN UNRECOGNIZED PROBLEM, Thrombosis research, 82(5), 1996, pp. 445-451
Authors:
WISLOFF F
HJORTH M
KAASA S
WESTIN J
Citation: F. Wisloff et al., EFFECT OF INTERFERON ON THE HEALTH-RELATED QUALITY-OF-LIFE OF MULTIPLE-MYELOMA PATIENTS - RESULTS OF A NORDIC RANDOMIZED TRIAL COMPARING MELPHALAN-PREDNISONE TO MELPHALAN-PREDNISONE PLUS ALPHA-INTERFERON, British Journal of Haematology, 94(2), 1996, pp. 324-332
Authors:
WISLOFF F
EIKA S
HIPPE E
HJORTH M
HOLMBERG E
KAASA S
PALVA I
WESTIN J
Citation: F. Wisloff et al., MEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN MULTIPLE-MYELOMA, British Journal of Haematology, 92(3), 1996, pp. 604-613
Authors:
HJORTH M
WESTIN J
DAHL IMS
GIMSING P
HIPPE E
HOLMBERG E
LAMVIK J
NIELSEN JL
LOFVENBERG E
PALVA IP
RODJER S
TALSTAD I
TURESSON I
WISLOFF F
ZADOR G
AMSLERNORDIN S
POLGARY M
ODEN A
WALLGREN A
WILHELMSEN L
HELLQVIST L
HASSELBLOM S
CARNESKOG J
LINDQVIST O
HOFFMAN P
OLSSON K
THOLEN A
STOLT CM
RINDNER A
SVENSSON R
VAART J
HANSEN S
ENGQVIST L
LANNEMYR O
NILSSON PG
LINNE I
LILJA G
TALLROTH G
HALLGREN J
ANDERSSON B
BILLSTROM R
PERSSON S
SAMUELSSON T
ODEBERG H
ADRIANSSON M
TOVE H
STOBEUS N
HABBERSTAD J
END T
DAHLEN M
ERIKSSON M
ANAGRIUS N
ARONSON D
NEZADAL L
ERIKSSON K
HEDENUS M
RYDE J
WESTIN L
ANDERSSON LO
BJURMAN A
FORSBERG K
FORS D
WIKSTROM S
THULE B
BOLSOY U
LENNERMO K
STRAND T
PALVA I
ALMQVIST A
ISOMAA B
OKSANEN K
EIKA C
LY B
BRANDT E
WEYDE K
FOSSUM C
LOVASEN K
SPARBY JA
JACOBSEN EM
RINDE M
NYHUS S
KAHRS J
STEEN T
GRAVDAHL H
BORGE L
GROTTUM KA
FLOTTEROD O
STROM BR
KNUTSEN H
DRIVENES A
PAULSEN J
RIIS S
HAUGE PW
NESTHUS I
COLL P
HOLE KH
SAETER T
SINDRE T
BERENTSEN S
NES H
VAGSTAD G
HEIKKELA R
SHAMMAS V
LODEMEL B
SKOGEN OR
SORUM Y
KVAMBE V
BULL O
JAEGER S
INGVALDSEN PG
PEDERSEN K
HANSEN LT
ONKIEHONG M
HAUGNES T
STEFANSEN D
GADEBERG O
ABILDGAARD N
JANS H
MOURITSANDERSEN T
NEUBAUER B
CLAUSEN NT
MAGNUSSON S
EYJOLFSSON G
BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
Authors:
SLETNES KE
GODAL HC
WISLOFF F
Citation: Ke. Sletnes et al., DISSEMINATED INTRAVASCULAR COAGULATION (DIC) IN ADULT PATIENTS WITH ACUTE-LEUKEMIA, European journal of haematology, 54(1), 1995, pp. 34-38
Authors:
SCHJETLEIN R
WISLOFF F
Citation: R. Schjetlein et F. Wisloff, DETECTION OF LUPUS ANTICOAGULANT - AN EVALUATION OF ROUTINES FOR PREPARATION AND STORAGE OF PLASMA, Thrombosis research, 79(1), 1995, pp. 135-140
Authors:
SCHJETLEIN R
WISLOFF F
Citation: R. Schjetlein et F. Wisloff, AN EVALUATION OF 2 COMMERCIAL TEST PROCEDURES FOR THE DETECTION OF LUPUS ANTICOAGULANT, American journal of clinical pathology, 103(1), 1995, pp. 108-111
Authors:
EVENSEN SA
BRINCH I
TJONNFJORD G
STAVEM P
WISLOFF F
Citation: Sa. Evensen et al., ESTIMATED 8-YEAR SURVIVAL OF MORE THAN 40-PERCENT IN A POPULATION-BASED STUDY OF 79 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 88(1), 1994, pp. 88-93
Authors:
KELDSEN N
BJERRUM OW
DAHL IMS
DRIVSHOLM A
ELLEGAARD J
GADEBERG O
GIMSING P
GRONVOLD T
HANSEN MM
HIPPE E
LAMVIK J
LY B
SKARBOVIK A
TALSTAD I
THORLING K
WESENBERG K
WISLOFF F
Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85